Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Balkan Med J ; 41(3): 193-205, 2024 May 03.
Artigo em Inglês | MEDLINE | ID: mdl-38700358

RESUMO

Background: Paclitaxel (PAX) is a widely used chemotherapy drug for various cancer types but often induces significant toxicity in multiple organ systems. Silymarin (SIL), a natural flavonoid, has shown therapeutic potential due to its multiple benefits. Aims: To evaluate the therapeutic efficacy of SIL in mitigating liver and kidney damage induced by PAX in rats, focusing on oxidative stress, inflammation, and apoptosis pathways. Study Design: Experimental animal model. Methods: The study included 28 male Wistar rats aged 12-14 weeks weighing 270-300 g. The rats were divided into four groups: control, SIL, PAX, and PAX + SIL, with seven in each group. The rats received intraperitoneal (i.p.) injections at a dose of 2 mg per kilogram of body weight of PAX for 5 successive days, followed by oral gavage with 200 mg/kg body mass of SIL for 10 uninterrupted days. We examined the effect of SIL on specific serum biochemical parameters using an autoanalyzer and rat-specific kits. The spectrophotometric methods was used to investigate oxidative stress indicators in kidney and liver tissues. Aquaporin-2 (AQP-2), B-cell lymphoma-2 (Bcl-2), cysteine aspartate-specific protease-3 (caspase-3), interleukin-6 (IL-6), nuclear factor kappa B (NF-κB), and streptavidin-biotin staining were used to assess immunoreactivity in PAX-induced liver and kidney injury models. Results: SIL treatment significantly reduced serum levels of alanine aminotransferase, aspartate aminotransferase, creatinine, urea, and C-reactive protein, indicating its effectiveness in treating PAX-induced liver and kidney injury. SIL treatment significantly reduced oxidative stress by increasing essential antioxidant parameters, such as superoxide dismutase, catalase, glutathione peroxidase, and glutathione. It also reduced malondialdehyde levels in liver and kidney tissues of SIL-PAX groups (p < 0.05). SIL administration reduced NF-κB, caspase-3, and IL-6 expression while increasing Bcl-2 and AQP2 levels in liver and kidney tissues of rats treated with SIL and PAX (p < 0.05). Conclusion: Our findings indicate the potential of SIL to alleviate PAX-induced liver and kidney damage in rats by reducing oxidative stress, inflammation, and apoptotic processes.


Assuntos
Apoptose , Inflamação , Estresse Oxidativo , Paclitaxel , Ratos Wistar , Silimarina , Animais , Estresse Oxidativo/efeitos dos fármacos , Ratos , Masculino , Apoptose/efeitos dos fármacos , Inflamação/tratamento farmacológico , Paclitaxel/farmacologia , Paclitaxel/uso terapêutico , Silimarina/farmacologia , Silimarina/uso terapêutico , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Fígado/efeitos dos fármacos , Rim/efeitos dos fármacos , Antineoplásicos Fitogênicos/uso terapêutico , Antineoplásicos Fitogênicos/farmacologia
2.
Medicina (Kaunas) ; 57(5)2021 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-33946186

RESUMO

Background and objectives: The whole world is spending an extraordinary effort by implementing various measures to control and prevent the COVID-19 pandemic. The effectiveness of the preventive measures is greatly influenced by the public's knowledge, attitudes, and practices (KAP) towards the disease. In this study, KAP values and some characteristic features of people recovered from COVID-19 were determined by conducting a questionnaire survey. Materials and Methods: The questionnaire survey was conducted between 1 and 10 January 2021 on people who recovered from COVID-19 in a total of 150 different locations in Turkey. The questionnaire consisted of 46 questions: 14 for determining demographic and some characteristic features of the participants, and 32 for determining their knowledge, attitudes, and practices. The data obtained were evaluated using descriptive statistics, chi-squared tests, t-tests, and one-way analysis of variance (ANOVA). Results: It was determined that 63% of the participants had at least one chronic illness, 3.9% suffered from the disease twice, and 45.2% changed their smoking habits. The average knowledge score of the participants about COVID-19 was calculated as 10.25 (SD = 2.37; range 0-15). The participants were found to have a high level of knowledge about the symptoms and prevention methods in general, and positive changes in post-illness attitudes and behaviors. However, there was a great instability regarding the drugs and vaccines used in the treatment of COVID-19. Conclusions: This was the first study carried out in Turkey to determine knowledge, attitudes, practices, and some characteristic features of people who recovered from COVID-19. It was suggested that health authorities in the country need to develop more effective strategies and policies to find out permanent solutions in order to control and prevent the COVID-19 pandemic by taking into account the concerns of the public, particularly with regards to the drugs used in the treatment and vaccination.


Assuntos
COVID-19 , Pandemias , Estudos Transversais , Conhecimentos, Atitudes e Prática em Saúde , Humanos , SARS-CoV-2 , Inquéritos e Questionários , Turquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA